Biggest Healthcare Stock Losers today were CEPH, PARD, SPEX : by Penny Stock Pick Alert

November 24, 2009

(EMAILWIRE.COM, November 24, 2009 ) Dallas, TX - Cephalon, Inc. (NASDAQ:CEPH) plunged 8.64% to $54.46 after Ception Therapeutics, Inc. and Cephalon, Inc., announced results from a Phase IIb/III clinical trial for CINQUIL as a treatment for pediatric eosinophilic esophagitis (EoE). The study was designed to evaluate improvement in the co-primary endpoints of changes in esophageal eosinophil levels and clinical symptoms. Analyses of the data indicated that patients treated with CINQUIL showed a statistically significant reduction in esophageal eosinophil levels versus placebo.

Poniard Pharmaceuticals, Inc. (NASDAQ:PARD) plunged 7.91% to $2.33. The stock hit an intraday high and an intraday low of $2.45 and $2.26 respectively. In the last six months the stock went down over 43%. Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of cancer therapy products. Its lead product candidate is picoplatin, a platinum-based cancer therapy.

Spherix Incorporated (NASDAQ:SPEX) plunged 9.77% to $1.57. The stock hit an intraday high and an intraday low of $1.74 and $1.56 respectively. In the last six months the stock went up over 41%. Spherix Incorporated operates through two business segments: Biospherics and Health Sciences. Biospherics is the Company's biotechnology research and development business. Health Sciences is a technical and regulatory consulting business.

ABOUT PennyStockPickAlert.com

Penny Stock Pick Alerts by PennyStockPickAlert.com. We are a leading stock web site that provides free stock alerts on top penny stocks that are poised to make big gains. We also tracks small cap penny stocks that could be on the brink of a massive breakout.


PennyStockPickAlert.com
Robert Wilson
214 556 6798
info@pennystockpickalert.com

Source: EmailWire.Com